Luis Miguel Gonzalez-Perez | Medicine | Best Researcher Award

Published on by Academic Excellence

Prof. Dr. Luis Miguel Gonzalez-Perez | Medicine | Best Researcher Award

Virgen del Rocío University Hospital | Spain

Luis Miguel González Pérez is a distinguished specialist in Oral and Maxillofacial Surgery with an extensive career dedicated to clinical practice, academic instruction, and research advancement. Serving as a Faculty Specialist at the Hospital Universitario Virgen del Rocío since 2000, he has contributed significantly to complex surgical care within the Andalusian Health Service. His expertise encompasses mandibular reconstruction, temporomandibular joint (TMJ) tumors, myofascial pain syndromes, and innovative approaches in oral mucosal repair. Since 2016, he has served as a Professor in the Master’s Program in Pain Treatment at the University of Sevilla, where he also holds a long-standing appointment as an Associate Professor in the Department of Surgery. His academic roles emphasize curriculum development, clinical training, and interdisciplinary teaching focused on maxillofacial pathology and surgical management. His excellence in teaching and clinical practice has been recognized through professional accreditations, including the Clinical Contracted Doctor Accreditation (2015) and an Excellent Level Professional Competency Accreditation by the Andalusian Agency for Healthcare Quality (2012). González Pérez has led and contributed to several ongoing research projects, particularly in biomedical innovation. His notable research initiatives include the application of biomaterials for mandibular reconstruction, long-term studies on TMJ tumors, clinical investigations into myofascial pain syndrome, and advancements in oral mucosal reconstruction using cryopreserved human amniotic membrane grafts. His work integrates clinical experience with translational research, contributing to improved therapeutic strategies in maxillofacial surgery. Through his combined roles as clinician, educator, and researcher, he continues to influence the progress of surgical sciences and enrich the training of future healthcare professionals.

Profiles: Scopus | Orcid

Featured Publications

Gonzalez-Perez, L.-M., Montes-Carmona, J.-F., Torres-Carranza, E., & Infante-Cossio, P. (2023). Total joint replacement for immediate reconstruction following ablative surgery for primary tumors of the temporo-mandibular joint. Journal of Personalized Medicine, 13(7), 1021.

Gonzalez-Perez, L.-M., Vera-Martin, R., Montes-Latorre, E., Torres-Carranza, E., & Infante-Cossio, P. (2023). Botulinum toxin and percutaneous needle electrolysis for the treatment of chronic masticatory myalgia. Toxins, 15(4), 278.

Cabrera-Arcas, A., Montes-Carmona, J.-F., & Gonzalez-Perez, L.-M. (2022). Mandibular radiolucencies: A differential diagnosis of a rare tumor. Diagnostics, 12(7), 1651.

Montes-Carmona, J.-F., Gonzalez-Perez, L.-M., & Infante-Cossio, P. (2020). Treatment of localized and referred masticatory myofascial pain with botulinum toxin injection. Toxins, 13(1), 6.

Gonzalez-Perez, L. M. (2020). Application of human amniotic membrane in temporomandibular joint osteoarthritis. Journal of Craniofacial Surgery, 31(4), e–? (PMID: 32195845).

Arusha Ayub | Medicine | Best Researcher Award

Published on by Academic Excellence

Ms. Arusha Ayub | Medicine | Best Researcher Award

University of Georgia | Georgia

Arusha Ayub is a dedicated final-year medical student at the University of Georgia, pursuing a Doctor of Medicine (MD) degree at the College of Health Sciences. Her academic journey began at the International Indian Embassy School in Riyadh, Saudi Arabia, where she completed both her secondary (2018) and senior secondary (2020) education under the CBSE board. Driven by a passion for advancing clinical and translational medicine, she has actively engaged in impactful research at both the University of Georgia and King Saud University. At the Scientific Research Institute, University of Georgia, Arusha has contributed as a research assistant to the project “Epidemiological Assessment of Living Indicators According to Systems in the Last Days of Life of Patients in the Terminal Phase of Cancer.” Her work focuses on assessing nutrition and gastrointestinal function in terminal cancer patients using a variety of standardized clinical assessment tools, thereby enhancing understanding of end-of-life care and patient quality of life. In addition, Arusha serves as a research intern under the mentorship of Dr. Sultan Meo at King Saud University, Riyadh. Her role involves participation in clinical studies emphasizing real-world data, study design, data collection, analysis, and manuscript development. Through collaboration with multidisciplinary teams, she has demonstrated excellence in research integrity, clinical evaluation, and scientific communication. Arusha’s academic rigor and research engagement reflect her commitment to integrating evidence-based medicine with compassionate healthcare practice, positioning her as a promising future physician and medical researcher.

Profile:  Google Scholar

Featured Publication

1. Samad, M. A., Ahmad, I., Hasan, A., Alhashmi, M. H., Ayub, A., Al‐Abbasi, F. A., et al. (2025). STAT3 signaling pathway in health and disease. MedComm, 6(4), e70152.

2. Ayub, A., Sultana, N., Faruk, M. I., Rahman, M. M., & Mamun, A. N. M. (2009). Control of rhizome rot disease of ginger (Zingiber officinale Rose) by chemicals, soil amendments, and soil antagonists. The Agriculturists, 12, 57–61.

3. Sultana, N., Ayub, A., & Islam, M. (2008). Yield loss assessment of onion bulb due to purple blotch disease. Annual Research Report, Plant Pathology Division, Bangladesh Agricultural Research Institute (BARI), Joydevpur.

4. Deshmukh, M., Madankar, R., Chaudhary, R. G., Kalam, M. A., Ayub, A., Mondal, A., et al. (2025). Bioinspired sustainable development of Ag-CuO/MWCNT nanocomposites for antibacterial applications. Microbial Pathogenesis, 203, 107516.

5. Latif, M., Hashmi, J. A., Alayoubi, A. M., Ayub, A., & Basit, S. (2024). Identification of novel and recurrent variants in BTD, GBE1, AGL and ASL genes in families with metabolic disorders in Saudi Arabia. Journal of Clinical Medicine, 13(5), 1193.

Priyanka Singh | Pharmacology | Women Researcher Award

Published on by Academic Excellence

Dr. Priyanka Singh | Pharmacology | Women Researcher Award

Technical University of Denmark | Denmark

Dr. Priyanka Singh is a Senior Researcher and Co-Principal Investigator at the Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark. With a PhD in Biomedical Science from Kyung Hee University, South Korea, and advanced training in microbiology from India, she has built an internationally recognized career at the intersection of nanomedicine, sustainable materials engineering, and translational therapeutics. Her research focuses on developing green nanomaterials, metallic nanoparticles, and chitosan-based systems for cancer therapy and combating antimicrobial resistance, particularly biofilm-associated infections. At DTU, she has played a pivotal role in establishing sustainable nanotherapeutic platforms, demonstrating efficacy in both advanced in vitro models and in vivo systems. She leads projects within major EU-funded consortia and has contributed to cutting-edge programs such as Marie Curie ITN and NordForsk collaborations. Dr. Singh has authored 88 peer-reviewed publications, garnering over 9,500 citations and an h-index of 46, earning recognition among the world’s top 2% scientists by Stanford University. Her scientific leadership extends to mentoring PhD and postdoctoral researchers, coordinating interdisciplinary projects, and promoting global collaboration as Regional Coordinator for IEEE Women in Nanotechnology (WIN). Her contributions have been recognized through multiple awards, including the Most Cited Paper Award in Nanobiotechnology (2024) and prestigious fellowships from Lundbeckfonden and the EU Marie Curie program. Beyond academia, she actively engages in science communication, mentorship, and editorial roles across leading journals. Driven by a vision to advance sustainable nanotherapeutics, Dr. Singh continues to pioneer research bridging nanotechnology, medicine, and sustainability.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

  • Biological synthesis of nanoparticles from plants and microorganisms  – P Singh, YJ Kim, D Zhang, DC Yang, Trends in Biotechnology 34(7), 588-599, 2016.

  • Gold nanoparticles in diagnostics and therapeutics for human cancer  – P Singh, S Pandit, V Mokkapati, A Garg, V Ravikumar, I Mijakovic, International Journal of Molecular Sciences 19(7), 1979, 2018.

  • Green synthesis of silver nanoparticles by Bacillus methylotrophicus, and their antimicrobial activity  – C Wang, YJ Kim, P Singh, R Mathiyalagan, Y Jin, DC Yang, Artificial Cells, Nanomedicine, and Biotechnology 44(4), 1127-1132, 2016.

  • Interactions of gold and silver nanoparticles with bacterial biofilms: Molecular interactions behind inhibition and resistance  – AS Joshi, P Singh, I Mijakovic, International Journal of Molecular Sciences 21(20), 7658, 2020.

  • Ecofriendly synthesis of silver and gold nanoparticles by Euphrasia officinalis leaf extract and its biomedical applications – H Singh, J Du, P Singh, TH Yi, Artificial Cells, Nanomedicine, and Biotechnology 46(6), 1163-1170, 2018.

Thomas Lehrnbecher | Medicine | Best Researcher Award

Published on by Academic Excellence

Prof. Dr. Thomas Lehrnbecher | Medicine | Best Researcher Award

Prof. Dr. Thomas Lehrnbecher | Medicine | Goethe Universität Frankfurt | Germany

Dr. Thomas Lehrnbecher is a distinguished pediatric oncologist and hematologist, serving as Head of the Division of Pediatric Hematology and Oncology at Johann Wolfgang Goethe University, Frankfurt. With decades of experience, his clinical and research expertise lies in infections in immunocompromised pediatric patients, supportive care, and innovative therapeutic strategies for childhood cancers. His career spans leading roles in Germany and international collaborations at the National Cancer Institute, USA, where he trained as a post-doctoral fellow. A prolific researcher, he has published extensively in high-impact journals, shaping global practices in infection management and antifungal prophylaxis in children with cancer. Dr. Lehrnbecher has also contributed significantly to medical societies, committees, and working groups, reflecting his leadership in advancing pediatric oncology. Recognized with prestigious awards, he continues to drive progress in medicine through innovative research, clinical care, and mentorship, making him an influential figure in pediatric hematology and oncology worldwide.

Author profile 

Orcid

Education

Dr. Lehrnbecher’s medical training reflects a strong foundation in pediatrics and subspecialization in oncology and infectious diseases. He earned his Board Exam in General Pediatrics in 1996, establishing his clinical foundation. His academic excellence and leadership were recognized in 2005, when he was awarded a Professorship at Johann Wolfgang Goethe University, Frankfurt, one of Germany’s leading medical institutions. That same year, he also earned a Diploma in Pediatric Infectious Diseases from the German Society for Pediatric Infectious Diseases, strengthening his expertise in managing complex infections. In 2007, he completed his Board Exam in Pediatric Hematology and Oncology, formally certifying his specialization in childhood cancers and blood disorders. Combined with his post-doctoral fellowship at the National Cancer Institute (NIH, USA), his education and training provided him with exceptional clinical and research competencies, which now serve as the foundation of his international reputation in pediatric oncology and infection medicine.

Experience

Dr. Lehrnbecher has cultivated an impressive career spanning over two decades in pediatric hematology and oncology. Since 2001, he has served as a Senior Consultant at Johann Wolfgang Goethe University, Frankfurt, providing expertise in pediatric cancer care and mentoring young clinicians. In 2018, he advanced to Head of the Division of Pediatric Hematology and Oncology, where he oversees patient care, clinical programs, and research initiatives. Earlier in his career, he worked as a Consultant at the Children’s Hospital, University of Würzburg (1999–2000), where he gained valuable clinical insights. A pivotal moment came during his post-doctoral fellowship at the National Cancer Institute, NIH, USA (1996–1999), under Dr. Stephen Chanock, where he developed a strong research focus on infections in immunocompromised children. His leadership in both clinical and research settings reflects his dedication to integrating science with practice, driving advancements in pediatric oncology, supportive care, and infection management worldwide.

Awards and Honors

Dr. Lehrnbecher’s contributions to pediatric oncology and infectious diseases have earned him numerous prestigious awards. In 2024, he received the Best Publication Award from the German Society of Mycology (DMykG), recognizing his impactful research. He previously won the Kind Philipp Award from the German Society of Pediatric Oncology and Hematology (GPOH) and the Poster Award from the International Society of Pediatric Oncology (SIOP). His groundbreaking work in mycology earned him the Outstanding Research in Mycology Award, while his contributions to histiocytic disorders were honored with the Nesbit Award from the Histiocyte Society. Earlier in his career, he was recognized with the Outstanding Research Award in Novel Therapeutic Strategies by the Children’s Cancer Foundation Mainz and the Educational Grant from the German Foundation of Cancer Aid. Collectively, these awards highlight his sustained excellence in clinical care, medical research, and innovation.

Research Focus

Dr. Lehrnbecher’s research is centered on improving the management of infections in immunocompromised pediatric patients, particularly those undergoing cancer treatment or hematopoietic stem cell transplantation. He has extensively studied antifungal prophylaxis, bacterial infections, and novel diagnostic markers for invasive fungal disease in children. His investigations aim to refine supportive care strategies, reduce infection-related mortality, and improve the quality of life for pediatric cancer patients. A particular focus of his research has been the efficacy of antifungal and antibiotic therapies, as well as the development of evidence-based guidelines for infection management. Beyond infectious diseases, his work also contributes to optimizing cancer treatment protocols, including long-term maintenance therapies for pediatric sarcomas. Through clinical trials, prospective studies, and international collaborations, Dr. Lehrnbecher has made significant advances in pediatric oncology. His contributions are widely recognized for bridging research and practice, helping set global standards for supportive care in children with cancer.

Publications

  • Assessing the Theoretical Efficacy of Combination Therapy Against Gram-Negative Infections in Neutropenic Pediatric Cancer Patients.

  • Mold-Active Antifungal Prophylaxis in Pediatric Patients with Cancer or Undergoing Hematopoietic Cell Transplantation.

  • Pediatric Patients with Stage IV Rhabdomyosarcoma Benefit from Long-Term Maintenance Therapy: CWS Trials Results.

  • Serum Beta-D-Glucan in the Diagnosis of Invasive Fungal Disease in Children: A Critical Analysis.

  • Cerebrospinal Fluid System Infection in Children with Cancer: A 14-Year Retrospective Analysis.

  • Infections during Non-Neutropenic Episodes in Pediatric Cancer Patients: A Prospective European Study.

Conclusion

Dr. Thomas Lehrnbecher is an internationally recognized leader in pediatric oncology and infectious diseases. His pioneering research, clinical leadership, and commitment to advancing supportive care in childhood cancer treatment have transformed patient outcomes worldwide. His achievements and continued impact make him a highly deserving candidate for the Medicine Award, symbolizing excellence in medical research and clinical innovation.

Inamul Hasan Madar | Medicine | Outstanding Scientist Award

Published on by Academic Excellence

Prof. Dr. Inamul Hasan Madar | Medicine | Outstanding Scientist Award

Prof. Dr. Inamul Hasan Madar | Medicine | Yenepoya Universtiy |India

Dr. Inamul Hasan Madar is a distinguished researcher and educator in the field of biochemistry with a specialization in oncology proteogenomics. He earned his PhD from Korea University, a globally ranked institution, and has since developed extensive expertise in cancer genomics, multiomics integration, and bioinformatics. With a strong commitment to advancing medical research, Dr. Madar has served as an adjunct faculty at Saveetha Medical College (SIMATS), where he has mentored PhD, MD, MBBS, and MSc students in cutting-edge biomedical sciences. His international research experience includes appointments at Korea University and Hanyang University in South Korea, where he contributed to high-impact oncology projects. As Director and Lead of Canary Oncoceutics India, he has bridged the gap between research and industry by leading innovative onco-therapeutic initiatives. Widely published in top-tier journals, Dr. Madar has also served as a reviewer for international journals and as a member of prestigious scientific societies worldwide.

Author profile

Orcid

Education

Dr. Madar’s academic journey reflects a deep pursuit of excellence in biomedical sciences. He earned his PhD in Biochemistry, specializing in Onco-Proteogenomics, from Korea University, Seoul, ranked among the top global universities. His doctoral work focused on proteogenomic profiling and cancer biomarker discovery, positioning him at the forefront of precision oncology. Before this, he pursued advanced training in bioinformatics, molecular biology, and proteomics, equipping him with multidisciplinary skills to tackle complex biomedical challenges. His postgraduate education emphasized molecular diagnostics and computational approaches, while his undergraduate studies laid the foundation in biochemistry and clinical applications. Dr. Madar has also completed specialized training programs in next-generation sequencing (NGS), computational modeling, molecular docking, and drug discovery pipelines. Furthermore, he has been actively engaged in faculty development programs, including pedagogy training for undergraduate teaching in life sciences and biotechnology. This comprehensive educational background underscores his ability to combine research innovation with academic excellence.

Experience

Dr. Madar’s professional experience spans academia, research, and industry. He currently serves as Adjunct Faculty at Saveetha Medical College, SIMATS, where he mentors MBBS, MD, MSc, MPhil, and PhD students in research methodologies, cancer biology, and bioinformatics. He is also Director and Lead (Marketing) at Canary Oncoceutics India, overseeing translational oncology research and innovation in oncoceutical product development. Internationally, he worked as a Visiting Scientist at Korea University, specializing in proteogenomics, and as a Researcher at Hanyang University, Seoul, in bioengineering. In India, his previous roles include Scientist & Course Coordinator at Biocuration, where he designed genomics and drug development modules, and Junior Scientist at iPro Technologies. He has also contributed as a guest lecturer at Bharathidasan University, training future biochemists. His expertise extends to designing computational pipelines, analyzing multiomics datasets, and leading cross-disciplinary projects that bridge laboratory science and clinical application, particularly in cancer therapeutics and biomarker discovery.

Awards and Honors

Dr. Inamul Hasan Madar has received widespread recognition for his contributions to biomedical research and education. His publications in high-impact journals such as Nature Cancer, Oncotarget, Briefings in Bioinformatics, and Molecular Cancer have positioned him among leading voices in proteogenomics and cancer research. He has served as a peer reviewer for several prestigious journals, including Nature’s Scientific Reports, Frontiers in Oncology, BMC Medical Genomics, and Journal of Translational Medicine. He has been actively involved in international professional societies, including the American Association of Cancer Research (AACR), American Society for Biochemistry and Molecular Biology (ASBMB), International Society of Computational Biology (ISCB), and South African and Korean Mass Spectrometry Societies. His leadership roles include serving as Vice President of ISCB-RSG India, demonstrating his dedication to strengthening scientific networks. He has also mentored numerous graduate and medical students, guiding them to publish impactful research, file patents, and develop translational medical applications.

Research Focus

Dr. Madar’s research focus lies at the intersection of cancer genomics, proteogenomics, and computational biology. He specializes in integrating multiomics datasets to identify novel biomarkers and therapeutic targets for treatment-resistant cancers, particularly cervical, prostate, and oral squamous cell carcinoma. His expertise in next-generation sequencing (RNA-Seq, Exome-Seq) and bioinformatics has enabled him to develop innovative pipelines for cancer biomarker discovery, molecular subtyping, and clinical variant interpretation. Beyond oncology, he has contributed to research in neurobiology, metabolic disorders, cardiovascular protection, and bioactive peptides against diabetes and obesity. His translational approach emphasizes the “bench-to-bedside” concept, applying computational models and molecular profiling to guide precision medicine strategies. Dr. Madar has also explored theranostic targets, signaling networks, and novel oncoceutical formulations. His interdisciplinary collaborations with international research groups have advanced drug design, CAR-T therapy applications, and personalized treatment strategies, positioning him as a pioneer in cancer research and translational medicine.

Publications

  • Correction to: Proteogenomic characterization of molecular and cellular targets for treatment-resistant cervical cancers.

  • Molecular analysis of HPV16 and HPV18 oncogenes in oral squamous cell carcinoma.

  • Proteogenomic characterization of treatment-resistant subtypes in cervical cancers.

  • Theranostic Target NSUN2 uncovered with systematic assembly of 805 datasets.

  • Unravelling the phosphoregulatory network of PKC-delta (PKC-δ).

  • BDNF-TrkB signalling: A neurotrophic pathway to cardiovascular protection.

  • Physiological activities of bioactive peptides against diabetes and obesity.

  • SGLT2 inhibitors as dual therapeutic targets for cardiovascular and renal health.

  • Biobased nanomaterials and rhizobacteria for sustainable plant growth.

  • CAR-T therapy in oral squamous cell carcinoma: Current innovations and future prospects.

Conclusion

Dr. Inamul Hasan Madar exemplifies excellence in translational medicine, combining cutting-edge cancer research with dedicated academic mentorship. His impactful publications, international collaborations, and leadership in oncology research position him as a transformative figure in biomedical sciences. Through his expertise in proteogenomics and bioinformatics, he continues to advance precision medicine while inspiring the next generation of medical researchers.

Syed Aasim Syed Nasir | Medicine | Excellence in Research

Published on by Academic Excellence

Mr. Syed Aasim Syed Nasir | Medicine | Excellence in Research

Mr. Syed Aasim Syed Nasir | Medicine | Tbilisi State Medical University | Georgia

Syed Aasim Syed Nasir is a dedicated fourth-year medical student at Tbilisi State Medical University, Georgia, committed to advancing medical research and clinical practice. His academic journey is complemented by extensive research contributions in cardiology, oncology, infectious diseases, and orthopedic surgery. With a growing publication record in reputed journals and conferences, he demonstrates strong skills in investigation, methodology, and medical writing. He has actively presented case reports, systematic reviews, and clinical studies at international platforms, earning recognition for his innovative insights. Beyond research, Syed Aasim is involved in leadership roles within medical organizations, fostering academic collaboration among peers worldwide. His internships and observerships in Dubai and Nigeria further enriched his exposure to diverse healthcare systems. Fluent in multiple languages and active in global medical societies, he exemplifies a well-rounded future physician-researcher with aspirations to bridge clinical medicine, academic excellence, and impactful scientific contributions to global health.

Author Profile

Orcid

Education

Syed Aasim Syed Nasir began his educational journey at Our Own English High School, Sharjah, UAE (2007–2019), where he developed a strong academic foundation. He then pursued his higher education at Velammal Vidhyashram School, Chennai, excelling in the sciences and preparing for a career in medicine. In 2021, he enrolled at Tbilisi State Medical University – School of Medicine, Georgia, where he is currently a Doctor of Medicine candidate. His education extends beyond formal coursework, as he participates in research training, medical writing, and scientific presentations at both national and international levels. His certifications in PALS, First Aid, CPR, ACLS, and BLS (in progress) add clinical preparedness to his academic excellence. Actively engaged in self-directed learning, he complements his curriculum with research in cardiology, oncology, and obstetrics, bridging classroom knowledge with real-world medical applications, shaping him into a future physician-scientist of global relevance.

Experience

Syed Aasim’s experience spans clinical exposure, research collaborations, leadership, and volunteerism. He completed observerships at Zulekha Hospital, Dubai, gaining insights into multidisciplinary patient care, and undertook a Psychnovation Neuroscience Internship, Nigeria, enhancing his research and clinical interpretation skills. He has served as a part-time researcher with the International Journal of Clinical Research (IJCR) and contributed to cardiology projects within IJCR Research Working Group. His leadership roles include General Secretary of ClinNova International, PR Team Member of IJCR Conference, Judiciary Council Member at GIMSOC, and University Head Representative. He also actively participated in Project IMG (USA) as a Unity Agent, furthering international student collaboration. His experiences combine academic rigor with hands-on exposure to clinical medicine, surgical case analysis, systematic reviews, and patient-centered research. These engagements reflect his commitment to developing as a medical leader, researcher, and clinician with both local and international impact.

Awards and Honors

Though early in his career, Syed Aasim has already earned recognition in multiple academic and professional avenues. His posters and case reports have been accepted and presented at high-impact platforms such as the Royal Society of London (2025) and the European Hip Society Congress, Thessaloniki, Greece (2025). His research on oncology, orthopedics, cardiology, and obstetrics has been acknowledged in international medical conferences, highlighting his ability to address complex diagnostic and therapeutic challenges. His selection as Georgia Ambassador for IJCR (2024–2025) underscores his leadership in research dissemination. Additionally, his active participation in medical student societies such as GIMSOC, SSSG, IASSS, and ClinNova International showcases his growing influence in academic medicine. These honors reflect both academic excellence and his proactive approach to advancing collaborative medical research. His consistent recognition in prestigious forums demonstrates his trajectory toward becoming a globally respected physician-researcher in medicine.

Research Focus

Syed Aasim’s research focuses on advancing clinical medicine through a multidisciplinary approach. His work spans oncology, cardiology, orthopedics, neurology, infectious diseases, and obstetrics/gynecology, reflecting his commitment to solving pressing healthcare challenges. He has investigated glioblastoma surgical outcomes, pharmacological mechanisms of UV-induced skin mutations, rheumatological impacts on cardiovascular health, and surgical complexities in gynecological disorders. His systematic reviews and meta-analyses address critical gaps in evidence-based medicine, such as hip arthroplasty, meniscal tear management, and cardiotoxicity biomarkers in cancer patients. He also explores therapeutics in infectious disease management, contributing reviews on measles outbreaks and innovative treatment strategies. His interest in women’s health and perinatal care is reflected in ongoing studies on melatonin supplementation in pregnancy and heart failure outcomes in women versus men. With a balance between clinical case reports, systematic reviews, and mechanistic research, his focus lies in generating translational insights that directly impact patient care and public health.

Publications

  1. A Diagnostic Chameleon: Genital Tuberculosis Mimicking Ovarian Malignancy – Case Report.

  2. Uterine Didelphys with OHVIRA Syndrome: Diagnostic and Surgical Challenges.

  3. Navigating the Pharmacological Landscape of UV-Induced Mutations in Skin Carcinogenesis.

  4. Comprehensive Review of Measles: Outbreak Trends, Clinical Manifestations, and Therapies.

  5. Glioblastoma Surgery: Comparative Study of Resection Degree and Survival Results.

  6. Rheumatoid Arthritis and Cardiovascular Mortality Trends in Postmenopausal Women.

  7. Glioblastoma Multiforme Surgery: Comparative Survival Investigation – IJCR 2024.

  8. Arthroscopic Partial Meniscectomy vs Exercise Therapy for Meniscal Tear: Systematic Review.

  9. Short Stem vs Standard Stem Total Hip Arthroplasty: A Systematic Review.

  10. Melatonin Supplementation in Pregnant Women: Neonatal Brain Maturation Study (In Progress).

  11. Impact of SGLT2 Inhibitors on HFpEF Outcomes: Gender-Based Analysis (In Progress).

  12. Rapid-Onset Obesity with Hypothalamic Dysfunction: Comprehensive Review (In Review).

  13. Infective Endocarditis Post-TAVR vs SAVR: A Comparative Study (In Review).

  14. NT-ProBNP/BNP vs Troponins in Chemotherapy-Induced Cardiotoxicity Detection (In Progress).

  15. Impact of Hydrotherapy in Sports Medicine (In Progress).

Conclusion

Syed Aasim Syed Nasir embodies the qualities of a future physician-scientist: rigorous academic training, international exposure, leadership in medical organizations, and impactful research contributions across diverse medical domains. His growing portfolio of publications, presentations, and leadership roles underscores his ability to bridge clinical practice and academic medicine. With a strong commitment to innovation and patient-centered research, he is positioned to make significant contributions to medicine and global healthcare. His trajectory reflects not only individual excellence but also the potential to influence future medical research and practice on a global scale.

 

Makiko Mitsunami | Medicine | Best Researcher Award

Published on by Academic Excellence

Dr. Makiko Mitsunami | Medicine | Best Researcher Award

Dr. Makiko Mitsunami, Integrated Center for Women’s Health, Japan

Dr. Makiko Mitsunami is a dedicated physician-scientist specializing in obstetrics, gynecology, and reproductive epidemiology. Born in Shiga, Japan, she obtained her MD from Jichi Medical University in 2008 and earned an MMSc from Harvard Medical School in Clinical Investigations. She later completed her PhD at Jichi Medical University, further enriching her academic prowess. Her professional journey includes rigorous clinical residency and postdoctoral research fellowships at prestigious institutions such as the Harvard T.H. Chan School of Public Health. Dr. Mitsunami’s research explores the intersection of nutrition, environmental health, and reproductive outcomes, with a strong focus on plant-based diets, infertility, and hormonal biomarkers. Her numerous grants and awards—including multiple research fundings from the Fuji Protein Foundation—underscore her impactful work. As a research associate at Harvard, she continues to mentor students and contribute to groundbreaking studies, advocating for women’s reproductive health globally through science and public health interventions.

Profile

Google Scholar

Suitability Summary for Research for Best Researcher Award

Dr. Makiko Mitsunami is an exemplary candidate for the Research for Best Researcher Award based on her robust academic background, extensive clinical and research experience, and impactful contributions to medical science, particularly in obstetrics, gynecology, and reproductive health. She holds an MD, MMSc in Clinical Investigations, and a PhD, combining rigorous clinical training with advanced research expertise from prestigious institutions such as Jichi Medical University and Harvard Medical School. This strong educational foundation supports her credibility and authority in her field.

Throughout her career, Dr. Mitsunami has balanced clinical responsibilities and academic pursuits, holding roles from junior resident to senior medical staff and research fellow. Her postdoctoral research experience at Harvard’s T.H. Chan School of Public Health highlights her commitment to advancing public health knowledge, particularly in areas such as nutrition, environmental health, and epidemiology, under the guidance of notable principal investigators. Her leadership experience as Associate Director of Obstetrics and Gynecology at Higashi-Ohmi General Medical Center further demonstrates her ability to integrate research with clinical practice and manage healthcare delivery effectively.

🎓 Education 

Dr. Makiko Mitsunami embarked on her academic journey at Jichi Medical University, where she earned her MD in 2008, followed by postgraduate residency training in obstetrics and gynecology across multiple medical centers in Japan. Pursuing a passion for clinical research, she enrolled in Harvard Medical School’s Master of Medical Sciences (MMSc) in Clinical Investigations, graduating in May 2021. She culminated her academic accomplishments with a PhD in Medicine from Jichi Medical University in 2023, reflecting a robust blend of clinical acumen and research excellence. Her academic path was enriched with prestigious international training experiences at Harvard T.H. Chan School of Public Health, where she contributed to studies on nutrition, epidemiology, and environmental health. Her cross-disciplinary education and commitment to women’s health have made her a prominent figure in reproductive medicine and global health. Her educational background empowers her ongoing contributions to cutting-edge research and healthcare improvement.

💼 Professional Experience 

Dr. Mitsunami’s professional experience spans clinical practice, academic appointments, and cutting-edge public health research. She began her career as a junior and senior resident in obstetrics and gynecology across several hospitals in Japan, including Otsu Red Cross and Shiga University of Medical Science Hospital. From 2012 to 2015, she served as a Visiting Assistant Professor of General Surgery, later becoming Associate Director of the Ob-Gyn department at Higashi-Ohmi General Medical Center. Her passion for research led her to the Harvard T.H. Chan School of Public Health, where she currently serves as a Postdoctoral Research Fellow and Research Associate under esteemed mentors such as Dr. Jorge Chavarro and Dr. Shruthi Mahalingaiah. Her research addresses nutrition, endocrine health, infertility, and environmental exposures. She has also contributed significantly to student training and curriculum development. Her diverse professional background uniquely positions her at the intersection of clinical medicine and impactful research.

🏅 Awards and Recognition

Dr. Makiko Mitsunami has been widely recognized for her contributions to reproductive medicine and clinical research. Early in her career, she received the Young Investigator’s Award in 2012 from the Society for Study of the Kidney in Pregnancy for her work on cardiomyopathy in dialysis patients. She has been awarded multiple competitive research grants from the Fuji Protein for Research Foundation between 2021 and 2025, totaling over $30,000 in support of her investigations into soy-based diets and reproductive health. In 2023, she was honored with the JMSA Scholarship from the Japanese Medical Society of America. Notably, she secured a prestigious Rotary Foundation Global Scholarship for her research on plant-based diets and hypertensive disorders during pregnancy, valued at $69,776. Additionally, she was selected as a Rose Service Learning Program Fellow at Harvard in 2024. These accolades reflect her growing global impact and academic excellence.

🌍 Research Skill On Medicine

Dr. Mitsunami brings a multifaceted research skill set to the field of reproductive medicine, grounded in clinical expertise and public health methodology. Her core research skills include epidemiologic study design, statistical data analysis, and translational research in human reproduction. She excels in linking environmental exposures and dietary patterns—especially plant-based diets—to hormonal health and fertility. Her work leverages biomarker analyses such as Anti-Müllerian Hormone (AMH) levels to evaluate ovarian reserve, endometriosis risk, and menopausal timing. Through her affiliations at Harvard T.H. Chan School of Public Health, she collaborates across departments of nutrition, epidemiology, and environmental health, contributing to multidisciplinary studies. Fluent in Japanese and English, she conducts culturally sensitive research on fertility awareness among Japanese populations in the U.S.. Her ability to secure funding, lead research protocols, and co-author impactful publications highlights her as a capable and forward-thinking researcher improving global reproductive outcomes.

📖 Publication Top Notes

  • Access to HPV vaccination in Japan: Increasing social trust to regain vaccine confidence
    Authors: K Kunitoki, M Funato, M Mitsunami, T Kinoshita, MR Reich
    Journal: Vaccine
    Volume(Issue): 39 (41), Pages: 6104-6110
    Citations: 42
    Year: 2021

  • Association of gestational diabetes with subsequent long-term risk of mortality
    Authors: YX Wang, M Mitsunami, JAE Manson, AJ Gaskins, JW Rich-Edwards, …
    Journal: JAMA Internal Medicine
    Volume(Issue): 183 (11), Pages: 1204-1213
    Citations: 37
    Year: 2023

  • Women’s and men’s intake of omega-3 fatty acids and their food sources and assisted reproductive technology outcomes
    Authors: A Salas-Huetos, M Arvizu, L Mínguez-Alarcón, M Mitsunami, …
    Journal: American Journal of Obstetrics and Gynecology
    Volume(Issue): 227 (2), Pages: 246.e1-246.e11
    Citations: 32
    Year: 2022

  • Paternal adherence to healthy dietary patterns in relation to sperm parameters and outcomes of assisted reproductive technologies
    Authors: A Salas-Huetos, L Mínguez-Alarcón, M Mitsunami, M Arvizu, JB Ford, …
    Journal: Fertility and Sterility
    Volume(Issue): 117 (2), Pages: 298-312
    Citations: 23
    Year: 2022

  • Physical activity before pregnancy and the risk of hypertensive disorders of pregnancy
    Authors: M Arvizu, L Minguez-Alarcon, JJ Stuart, M Mitsunami, B Rosner, …
    Journal: American Journal of Obstetrics & Gynecology MFM
    Volume(Issue): 4 (2), Article: 100556
    Citations: 19
    Year: 2022

  • Pre-pregnancy menstrual cycle regularity and length and the risk of gestational diabetes mellitus: prospective cohort study
    Authors: YX Wang, S Wang, M Mitsunami, JAE Manson, JW Rich-Edwards, …
    Journal: Diabetologia
    Volume(Issue): 64 (11), Pages: 2415-2424
    Citations: 14
    Year: 2021

  • A dietary score representing the overall relation of men’s diet with semen quality in relation to outcomes of infertility treatment with assisted reproduction
    Authors: M Mitsunami, A Salas-Huetos, L Mínguez-Alarcón, JA Attaman, JB Ford, …
    Journal: F&S Reports
    Volume(Issue): 2 (4), Pages: 396-404
    Citations: 12
    Year: 2021

  • Prepregnancy healthy lifestyle and adverse pregnancy outcomes
    Authors: S Wang, M Mitsunami, E Ortiz-Panozo, CW Leung, JAE Manson, …
    Journal: Obstetrics & Gynecology
    DOI: 10.1097
    Citations: 11
    Year: 2022

  • Men’s dietary patterns in relation to infertility treatment outcomes among couples undergoing in vitro fertilization
    Authors: M Mitsunami, A Salas-Huetos, L Mínguez-Alarcón, JA Attaman, JB Ford, …
    Journal: Journal of Assisted Reproduction and Genetics
    Volume(Issue): 38 (9), Pages: 2307-2318
    Citations: 11
    Year: 2021

  • Women’s adherence to healthy dietary patterns and outcomes of infertility treatment
    Authors: A Salas-Huetos, M Mitsunami, S Wang, L Mínguez-Alarcón, …
    Journal: JAMA Network Open
    Volume(Issue): 6 (8), Article: e2329982
    Citations: 10
    Year: 2023

 

Maximino Redondo | Health Professions | Best Scholar Award

Published on by Academic Excellence

Prof. Dr. Maximino Redondo | Health Professions | Best Scholar Award

Prof. Dr. Maximino Redondo, Universidad de Málaga, Spain

Dr. Maximino Redondo Bautista is an accomplished Spanish physician and professor, with an extensive career in clinical laboratory medicine and health research. Since 1993, he has served as a Medical Specialist at Hospital Universitario Costa del Sol in Málaga, while concurrently advancing academia as a full-time professor at the University of Málaga. With six recognized research sexennia and leadership of the hospital’s Research Unit, Dr. Redondo has made significant strides in translational medicine, oncology, and chronic disease studies. He has led 18 competitive research projects supported by the Instituto de Salud Carlos III and regional health bodies. His international collaborations and contributions to multicenter studies have shaped evidence-based healthcare practices in Spain. Through consistent involvement in national research networks like REDISSEC and RICAPPS, he promotes innovation, training, and the implementation of real-world healthcare solutions.

Profile

Google Scholar

🌟 Assessment of Suitability for the Research for Best Scholar Award: Dr. Maximino Redondo Bautista

Summary of Suitability:

Dr. Maximino Redondo Bautista stands as a highly qualified candidate for the Research for Best Scholar Award, bringing decades of academic, clinical, and research excellence to the forefront. With a strong dual appointment as a Medical Specialist at the Hospital Universitario Costa del Sol since 1993 and a Full Professor (Catedrático) at the University of Málaga since 2023, his contributions straddle both advanced medical practice and academic leadership.

Dr. Redondo earned his Doctorate in Medicine and Surgery from the University of Granada in 1991, along with specialized academic training in Epidemiology and Clinical Research. His professional journey reflects a consistent climb, with long-term involvement in academia and research, having held multiple professorial roles and received continuous competitive research funding. Over the years, he has served as Principal Investigator in 18 competitive research projects funded by the Instituto de Salud Carlos III and the Andalusian Health Council.

🎓 Education

Dr. Redondo holds a Doctorate in Medicine and Surgery from the University of Granada (1991), which laid the groundwork for his specialization in clinical analysis and translational medical research. He also earned a University Expert Degree in Epidemiology and Clinical Research from the same university in 2000. His academic journey began with a residency (MIR) in Clinical Analysis at the University Hospital Virgen de las Nieves (1986–1990), followed by key professional training in top Spanish medical centers. Over the years, he has cultivated a strong background in biomedical sciences and public health, supported by further academic certification and participation in national programs. His extensive formal education, complemented by teaching roles since 1992, has empowered him to nurture emerging scientists, shape academic curricula, and contribute to policy-oriented research in health sciences.

💼 Professional Experience

Dr. Maximino Redondo has more than three decades of experience in clinical medicine, research, and higher education. Since 1993, he has worked as a Clinical Laboratory Specialist at Hospital Universitario Costa del Sol. In academia, he has been a professor at the University of Málaga since 1992, most recently serving as Chair Professor in the Department of Surgical Specialties, Biochemistry, and Immunology. He also served as a Tenured Professor and Associate Professor over the years. His extensive career includes significant research leadership: serving on competitive programs at Instituto de Salud Carlos III and the Andalusian Health Council. He coordinates national research networks, leads clinical studies, and contributes to translational research initiatives. Dr. Redondo’s integrated professional approach bridges patient care, scientific inquiry, and academic excellence, shaping policy and fostering innovation in health service delivery.

🏅 Awards and Recognition 

Dr. Redondo has been widely recognized for his exceptional contributions to biomedical research, health policy, and academic mentorship. His work has earned six officially recognized sexenios de investigación (six-year research productivity periods), a distinguished mark in Spanish academia. He has led 18 competitive research projects and was repeatedly selected for national Intensification Programs by both Instituto de Salud Carlos III and the Andalusian Ministry of Health. Dr. Redondo played a central role in the REDISSEC and RICAPPS research networks, coordinating multicenter studies and leading national healthcare strategies. His efforts have translated research findings into impactful healthcare practices and evidence-based policy reforms. As a principal investigator and mentor, he has contributed to researcher training programs and advanced Spain’s health system through innovation and collaborative research. His influence spans medical education, diagnostics, and national public health frameworks.

🌍 Research Skills On Health Professions

Dr. Redondo excels in translational research, clinical epidemiology, biostatistics, and health services evaluation. His primary focus lies in oncology, chronic illness management, and the integration of research findings into real-world clinical practice. His skillset includes designing multicenter studies, applying evidence-based medicine, and leveraging laboratory diagnostics to inform health policies. As a senior researcher and group leader in the RICAPPS (RD21/0016/0015 and RD24/0005/0016) and REDISSEC networks, he coordinates collaborative research among hospitals, universities, and institutes across Spain. He also mentors early-career researchers, promotes interdisciplinary partnerships, and strengthens knowledge translation in healthcare. His ability to secure competitive funding and lead innovative health projects demonstrates scientific and managerial expertise. Dr. Redondo also contributes to editorial, evaluation, and strategic committees, ensuring the long-term sustainability and impact of research initiatives aimed at improving public health outcomes.

📖 Publication Top Notes

  • 🔬 Overexpression of clusterin in human breast carcinoma
    Authors: M. Redondo, E. Villar, J. Torres-Muñoz, T. Tellez, M. Morell, C.K. Petito
    Citation: The American Journal of Pathology, 157(2), 393–399.
    Year: 2000

  • 🧪 Immunotherapy: a challenge of breast cancer treatment
    Authors: M. García-Aranda, M. Redondo
    Citation: Cancers, 11(12), 1822.
    Year: 2019

  • 🧫 Expression of prostate specific membrane antigen (PSMA) in prostatic adenocarcinoma and prostatic intraepithelial neoplasia
    Authors: C. Marchal, M. Redondo, M. Padilla, J. Caballero, I. Rodrigo, J. Garcia, et al.
    Citation: Histology and Histopathology, 2004.
    Year: 2004

  • 🧠 Deletion of lysophosphatidic acid receptor LPA1 reduces neurogenesis in the mouse dentate gyrus
    Authors: E. Matas-Rico, B. Garcia-Diaz, P. Llebrez-Zayas, D. López-Barroso, L. Santin, M. Redondo, et al.
    Citation: Molecular and Cellular Neuroscience, 39(3), 342–355.
    Year: 2008

  • 💉 Bcl-2 inhibition to overcome resistance to chemo- and immunotherapy
    Authors: M. García-Aranda, E. Pérez-Ruiz, M. Redondo
    Citation: International Journal of Molecular Sciences, 19(12), 3950.
    Year: 2018

  • 🧬 Presence of HPV 16 sequences in laryngeal carcinomas
    Authors: M. Perez-Ayala, F. Ruiz-Cabello, F. Esteban, A. Concha, M. Redondo, et al.
    Citation: International Journal of Cancer, 46(1), 8–11.
    Year: 1990

  • 🧻 The substance P/NK-1 receptor system: NK-1 receptor antagonists as anti-cancer drugs
    Authors: M. Muñoz, R. Coveñas, F. Esteban, M. Redondo
    Citation: Journal of Biosciences, 40, 441–463.
    Year: 2015

  • 🫁 Expression of HLA class I and II antigens in bronchogenic carcinomas: its relationship to cellular DNA content and clinical-pathological parameters
    Authors: M. Redondo, A. Concha, R. Oldiviela, A. Cueto, A. Gonzalez, F. Garrido, et al.
    Citation: Cancer Research, 51(18), 4948–4954.
    Year: 1991

  • 🔬 NK-1 receptor antagonists induce apoptosis and counteract substance P-related mitogenesis in human laryngeal cancer cell line HEp-2
    Authors: M. Muñoz, M. Rosso, F.J. Aguilar, M.A. González-Moles, M. Redondo, et al.
    Citation: Investigational New Drugs, 26, 111–118.
    Year: 2008

  • 🎯 Protein kinase targets in breast cancer
    Authors: M. García-Aranda, M. Redondo
    Citation: International Journal of Molecular Sciences, 18(12), 2543.
    Year: 2017

Abu Shonchoy | Health | Best Researcher Award

Published on by Academic Excellence

Assoc. Prof. Dr. Abu Shonchoy | Health | Best Researcher Award

Assoc. Prof. Dr. Abu Shonchoy, Florida International University, United States

Dr. Abu S. Shonchoy is a distinguished economist and Associate Professor at Florida International University (FIU), USA. With a deep-rooted passion for development and labor economics, his research explores innovative policy interventions addressing poverty, migration, and digital finance. He has held key research affiliations with Abdul Latif Jameel Poverty Action Lab (J-PAL) at MIT and the IZA Institute of Labor Economics. A prolific academic, Dr. Shonchoy has significantly contributed to understanding the socio-economic impact of technology adoption, financial inclusion, and education policies. His work is widely published in high-impact journals, making him a leading voice in global economic research. With a PhD from the University of New South Wales, his expertise spans across continents, shaping economic policies in both developed and developing nations. He continues to advance impactful research that drives socio-economic transformations worldwide.

Professional Profile

Scopus

Orcid

Google Scholar

Suitability for the "Research for Best Researcher Award" – Abu S. Shonchoy

Abu S. Shonchoy stands out as an exemplary candidate for the "Research for Best Researcher Award" due to his profound contributions to Development and Labor Economics. As an Associate Professor at Florida International University (FIU), his career trajectory is marked by significant academic achievements, particularly in the areas of poverty, migration, health economics, and social identity, which directly align with the award's focus on impactful research.

Shonchoy's research interests span behavioral and experimental economics, with a strong focus on real-world challenges, such as understanding the effects of COVID-19 lockdowns on neonatal mortality, promoting digital financial technology adoption in crises, and the impacts of early childhood human capital formation. His work has consistently led to high-quality publications in top-tier journals like Journal of Health Economics, Nature Scientific Reports, and World Development, cementing his standing as a thought leader in his field.

Education

Dr. Abu S. Shonchoy’s academic journey is a testament to his dedication to economic research. He earned his PhD in Economics from the University of New South Wales (UNSW), Australia, in 2011, specializing in development and labor economics. Prior to this, he completed a Master of Economic Policy from the Australian National University (ANU) in 2005, where he was awarded the prestigious Neil Vousden Memorial Scholarship. His foundational studies include a Bachelor of Social Sciences in Economics (First Class Honors) from the University of Dhaka, Bangladesh, in 2003. His academic training, enriched by global exposure, laid the groundwork for his extensive contributions to economic research. Dr. Shonchoy's educational background has enabled him to drive impactful research in poverty alleviation, financial technology, and labor markets, significantly influencing policy decisions worldwide.

Professional Experience

Dr. Abu S. Shonchoy has built an illustrious academic career, currently serving as an Associate Professor of Economics (tenured) at Florida International University (FIU) since 2021. He is also an Affiliated Professor at Abdul Latif Jameel Poverty Action Lab (J-PAL) and a Research Fellow at IZA and GLO. Previously, he was an Assistant Professor at FIU (2018-2021), a Research Fellow at IDE-JETRO, Japan (2010-2018), and a Visiting Scholar at New York University (2016-2018). His experience also includes teaching roles at the University of Tokyo and National Graduate Institute for Policy Studies (GRIPS). With a global research footprint, Dr. Shonchoy has been instrumental in shaping policies in financial inclusion, poverty reduction, and labor economics. His interdisciplinary approach and collaborations have positioned him as a thought leader in economic development.

Awards and Recognition 

Dr. Abu S. Shonchoy’s contributions have earned him numerous accolades. In 2024, he received the prestigious FIU Top Scholar Award and the ADB-IEA Innovative Policy Research Award. His earlier recognitions include the Albert Berry Prize from the Canadian Economic Association (2016) and the Best Young Researcher Presentation Award at the ADB-3ie conference (2014). His excellence in teaching was acknowledged with the Highest Student Evaluation Score at the University of Technology Sydney (2010). A recipient of the Sasakawa Young Leaders Fellowship and Neil Vousden Memorial Scholarship, Dr. Shonchoy has consistently demonstrated academic and research excellence. His work has been recognized internationally, reinforcing his influence in economic policy development. These accolades highlight his impactful research in labor economics, digital finance, and socio-economic policy interventions.

Research Skills On Health

Dr. Abu S. Shonchoy’s research expertise encompasses development economics, labor economics, behavioral economics, and financial inclusion. He specializes in designing and evaluating randomized controlled trials (RCTs) to assess the impact of financial technology and education policies. His work integrates quantitative analysis, big data methodologies, and experimental approaches to derive actionable policy insights. His research on digital financial inclusion has shaped policies in emerging economies, and his interdisciplinary studies have contributed to social mobility, migration, and economic resilience. As an editorial board member for Nature – Scientific Reports, he continuously advances the frontiers of knowledge in his field. His ability to translate complex economic theories into practical policy recommendations makes him a key influencer in global economic research.

Publication Top Notes

  • Poverty and migration in the digital age: Experimental evidence on mobile banking in Bangladesh

    • Authors: JN Lee, J Morduch, S Ravindran, A Shonchoy, H Zaman

    • Citations: 215

    • Year: 2021

  • Migration, externalities, and the diffusion of COVID-19 in South Asia

    • Authors: JN Lee, M Mahmud, J Morduch, S Ravindran, AS Shonchoy

    • Citations: 81

    • Year: 2021

  • Can solar lanterns improve youth academic performance? Experimental evidence from Bangladesh

    • Authors: Y Kudo, AS Shonchoy, K Takahashi

    • Citations: 66

    • Year: 2019

  • Determinants of government consumption expenditure in developing countries: A panel data analysis

    • Author: AS Shonchoy

    • Citations: 50

    • Year: 2010

  • Narrowing the gender gap in mobile banking

    • Authors: JN Lee, J Morduch, S Ravindran, AS Shonchoy

    • Citations: 49

    • Year: 2022

  • The informal labour market in India: Transitory or permanent employment for migrants?

    • Authors: A Shonchoy, PNR Junankar

    • Citations: 48

    • Year: 2014

  • Impact of electrification on children’s nutritional status in rural Bangladesh

    • Authors: T Fujii, AS Shonchoy, S Xu

    • Citations: 47

    • Year: 2018

  • Fertility and rural electrification in Bangladesh

    • Authors: T Fujii, AS Shonchoy

    • Citations: 38

    • Year: 2020

  • The impact of a computer-based adult literacy program on literacy and numeracy: Evidence from India

    • Authors: A Deshpande, A Desrochers, C Ksoll, AS Shonchoy

    • Citations: 37

    • Year: 2017

  • Primary, secondary, and tertiary education in Bangladesh: Achievements and challenges

    • Authors: H Kono, Y Sawada, AS Shonchoy

    • Citations: 30

    • Year: 2018

Wentao Han | Medicine | Best Researcher Award

Published on by Academic Excellence

Dr. Wentao Han | Medicine | Best Researcher Award

Dr. Wentao Han, Department of Ophthalmology, The Second Xiangya Hospital, Central South University, China

Wentao Han is a dedicated ophthalmology researcher specializing in diabetic eye complications, dry eye syndrome, and gene therapy. Currently pursuing his research at the Second Xiangya Hospital of Central South University, China, he has demonstrated a strong passion for advancing medical science through innovative studies. His contributions to ocular disease research, particularly in understanding the gut-eye axis and corneal wound healing, highlight his interdisciplinary approach. He has authored multiple high-impact journal articles and actively collaborates with global scholars. His research on machine learning applications in medical diagnosis showcases his forward-thinking vision in integrating AI with healthcare. Beyond academia, Wentao Han serves as a reviewer for prestigious journals, contributing to the integrity of scientific publications. His dedication to translational medicine and biomarker identification continues to shape new therapeutic strategies. His work aims to bridge laboratory findings with clinical applications, improving patient outcomes in ophthalmology and metabolic diseases.

Professional Profile 

Orcid

Suitability for the Research for Best Researcher Award – Wentao Han

Wentao Han demonstrates a strong research background in ophthalmology, particularly in the areas of diabetic eye complications, dry eye syndrome, and corneal wound healing. Currently pursuing research at the Second Xiangya Hospital of Central South University, he has made notable contributions to the field, with multiple high-impact publications in reputable journals. His expertise in the “gut metabolites–inflammation–eye axis” and gene therapy for Meibomian Gland Dysfunction (MGD) highlights his innovative approach to addressing critical challenges in ophthalmology.

His publication record is impressive, with multiple papers in Q1 and Q2 journals, including Pharmaceutics, The Ocular Surface, Acta Diabetologica, and Journal of Medical Internet Research. Notably, his work on machine learning prediction models, autophagy in retinal precursor cells, and the gut-eye axis showcases a multidisciplinary research approach. His role as an invited reviewer for respected journals further establishes his credibility in the academic community.

🎓 Education 

Wentao Han is currently pursuing advanced medical research at Central South University, Changsha, China, within the Department of Ophthalmology at the Second Xiangya Hospital. His academic journey reflects a deep commitment to ophthalmic research, focusing on diabetic retinopathy, ocular surface disorders, and corneal healing mechanisms. Through rigorous training and hands-on experience in clinical settings, he has honed his expertise in evidence-based medicine and translational research. His coursework and mentorship under leading ophthalmologists have allowed him to integrate molecular biology with patient-centered investigations. Additionally, he actively participates in research seminars, workshops, and scientific collaborations, reinforcing his knowledge of bioinformatics, gene therapy, and regenerative medicine. His strong foundation in medical sciences, combined with a keen interest in technological advancements, positions him as a promising young researcher in ophthalmology. His education has equipped him with critical skills to contribute to groundbreaking discoveries in the field of ocular diseases.

💼 Professional Experience 

As a researcher in ophthalmology at the Second Xiangya Hospital of Central South University, Wentao Han has contributed significantly to understanding diabetic eye complications and ocular disease mechanisms. His professional experience includes conducting clinical and preclinical studies on dry eye syndrome, corneal wound healing, and the gut-eye axis. He has extensive expertise in meta-analyses, molecular diagnostics, and the application of artificial intelligence in disease prediction. His work in identifying novel biomarkers for diabetic retinopathy has been widely recognized. Additionally, he collaborates with interdisciplinary teams, integrating bioinformatics and evidence-based medicine to develop innovative treatment approaches. Han’s active involvement in academic publishing and peer review for high-impact journals reflects his commitment to advancing medical knowledge. His current projects involve investigating gene therapy for meibomian gland dysfunction and corneal regeneration, with the aim of translating scientific discoveries into clinical applications that enhance patient care in ophthalmology.

🏅 Awards and Recognition 

Wentao Han has received multiple recognitions for his outstanding contributions to ophthalmic research. He has been an invited reviewer for prestigious journals such as Cell Death Discovery (IF = 7) and Acta Diabetologia (IF = 3.9), underscoring his expertise in diabetes-related ocular disorders. His research on gut metabolites’ role in eye diseases has been acknowledged at international conferences. Several of his published articles in Q1 journals have earned high citations, reflecting their impact on the scientific community. Han has also contributed to the development of machine learning prediction models for gestational diabetes mellitus, further showcasing his interdisciplinary proficiency. His involvement in groundbreaking studies on corneal wound healing has positioned him as a promising young researcher in ophthalmology. With a strong publication record, peer recognition, and contributions to medical advancements, Han continues to be a driving force in translational ophthalmic research and clinical innovation.

🌍 Research Skills On Medicine

Wentao Han possesses a diverse set of research skills that bridge molecular biology, clinical medicine, and artificial intelligence applications in ophthalmology. His expertise includes conducting systematic reviews, meta-analyses, and experimental research on diabetic retinopathy and dry eye syndrome. He is proficient in bioinformatics tools for gene analysis and biomarker identification, which he applies to precision medicine. Han is skilled in laboratory techniques such as immunohistochemistry, cell culture, and animal models for ocular disease studies. His ability to integrate AI and machine learning into medical research has led to innovative predictive models for disease diagnosis. Additionally, his work in gene therapy for corneal and meibomian gland dysfunction highlights his translational research capabilities. Han’s interdisciplinary approach allows him to explore novel therapeutic targets, making significant contributions to evidence-based medicine. His research aims to improve diagnostic accuracy and therapeutic interventions in ophthalmic and metabolic disorders.

📖 Publication Top Notes

  • Research Progress and Potential Applications of Spermidine in Ocular Diseases
  • Machine Learning Prediction Models for Gestational Diabetes Mellitus: Meta-analysis
    • Authors: Zheqing Zhang, Luqian Yang, Wentao Han, Yaoyu Wu, Linhui Zhang, Chun Gao, Kui Jiang, Yun Liu, Huiqun Wu
    • Citation: Journal of Medical Internet Research, 2022-03-16
    • Year: 2022
    • DOI: 10.2196/26634
  • Genome Analysis and Identification of Key Pathway in Visceral Adipose Tissue from Obesity-Related Diabetes
    • Authors: Wentao Han
    • Citation: Proceedings of the 2021 International Conference on Bioinformatics and Intelligent Computing, 2021-01-22
    • Year: 2021
    • DOI: 10.1145/3448748.3448757
  • Machine Learning Prediction Models for Gestational Diabetes Mellitus: Meta-analysis (Preprint)
    • Authors: Zheqing Zhang, Luqian Yang, Wentao Han, Yaoyu Wu, Linhui Zhang, Chun Gao, Kui Jiang, Yun Liu, Huiqun Wu
    • Citation: Preprint, 2020-12-19
    • Year: 2020
    • DOI: 10.2196/preprints.26634
  • Construction of a Knowledge Graph for Diabetes Complications from Expert-Reviewed Clinical Evidences
    • Authors: Wentao Han
    • Citation: Computer Assisted Surgery (Abingdon, England), 2020-11-25
    • Year: 2020
    • DOI: 10.1080/24699322.2020.1850866
    • PMID: 33275462
  • Association Between Retinol Binding Protein 4 and Diabetic Retinopathy Among Type 2 Diabetic Patients: A Meta-analysis
    • Authors: Wentao Han, Huagen Wei, Weizheng Kong, Jing Wang, Luqian Yang, Huiqun Wu
    • Citation: Acta Diabetologica, 2020-10
    • Year: 2020
    • DOI: 10.1007/s00592-020-01535-3